Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Genmab A/S Sponsored ADR (GMAB) had Stock-Based Compensation of $25.00M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$715.00M |
|
$195.00M |
|
$42.00M |
|
$673.00M |
|
$527.00M |
|
$188.00M |
|
$56.00M |
|
$244.00M |
|
$244.00M |
|
$195.00M |
|
$195.00M |
|
$195.00M |
|
$195.00M |
|
$188.00M |
|
$204.00M |
|
637.25M |
|
639.34M |
|
$0.31 |
|
$0.30 |
|
| Balance Sheet Financials | |
$4.04B |
|
$145.00M |
|
$2.55B |
|
$6.59B |
|
$756.00M |
|
-- |
|
$534.00M |
|
$1.29B |
|
$5.30B |
|
$3.19B |
|
$5.30B |
|
661.97M |
|
| Cash Flow Statement Financials | |
$287.00M |
|
$-43.00M |
|
$-13.00M |
|
$1.38B |
|
$1.62B |
|
$239.00M |
|
|
Stock-Based Compensation |
$25.00M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
94.13% |
|
26.29% |
|
26.29% |
|
-- |
|
34.13% |
|
27.27% |
|
$275.00M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
3.50 |
|
0.89 |
|
100.57 |
|
3.68% |
|
6.12% |
|
2.96% |
|
3.68% |
|
$8.00 |
|
$0.43 |
|
$0.45 |
|